Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

Loss of autophagy impairs physiological steatosis by accumulation of NCoR1

Shun-saku Takahashi, Yu-Shin Sou, Tetsuya Saito, Akiko Kuma, Takayuki Yabe, Yuki Sugiura, View ORCID ProfileHyeon-Cheol Lee, Makoto Suematsu, Takehiko Yokomizo, View ORCID ProfileMasato Koike, Shuji Terai, View ORCID ProfileNoboru Mizushima, Satoshi Waguri, View ORCID ProfileMasaaki Komatsu  Correspondence email
Shun-saku Takahashi
1Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Shin Sou
2Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuya Saito
3Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Kuma
4Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, the University of Tokyo, Bunkyo-ku, Tokyo, Japan
5Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takayuki Yabe
6Department of Anatomy and Histology, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuki Sugiura
7Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyeon-Cheol Lee
8Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hyeon-Cheol Lee
Makoto Suematsu
7Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takehiko Yokomizo
8Department of Biochemistry, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Koike
2Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masato Koike
Shuji Terai
1Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noboru Mizushima
4Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, the University of Tokyo, Bunkyo-ku, Tokyo, Japan
5Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noboru Mizushima
Satoshi Waguri
6Department of Anatomy and Histology, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaaki Komatsu
3Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masaaki Komatsu
  • For correspondence: mkomatsu@juntendo.ac.jp
Published 26 December 2019. DOI: 10.26508/lsa.201900513
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Abstract

Lipid droplets (LDs) are dynamic organelles that store neutral lipids during times of energy excess, such as after a meal. LDs serve as an energy reservoir during fasting and have a buffering capacity that prevents lipotoxicity. Autophagy and the autophagic machinery have been proposed to play a role in LD biogenesis, but the underlying molecular mechanism remains unclear. Here, we show that when nuclear receptor co-repressor 1 (NCoR1), which inhibits the transactivation of nuclear receptors, accumulates because of autophagy suppression, LDs decrease in size and number. Ablation of ATG7, a gene essential for autophagy, suppressed the expression of gene targets of liver X receptor α, a nuclear receptor responsible for fatty acid and triglyceride synthesis in an NCoR1-dependent manner. LD accumulation in response to fasting and after hepatectomy was hampered by the suppression of autophagy. These results suggest that autophagy controls physiological hepatosteatosis by fine-tuning NCoR1 protein levels.

Introduction

Lipid droplets (LDs) are neutral lipid storage organelles that provide fatty acids (FAs) for energy production during periods of nutrient deprivation. These organelles, which emerge from the ER, also have a lipid buffering capacity that helps prevent lipotoxicity (1, 2). Enzymes involved in triacylglycerol (TG) synthesis, such as diacylglycerol O-acyltransferase (DGAT), deposit neutral lipids in between the leaflets of the ER bilayer where neutral lipids demix and coalesce to form a structure called an oil lens. Thereafter, seipin and other LD biogenesis factors facilitate the growth of nascent LDs from this lens. LDs bud from the ER and grow through either fusion or local lipid synthesis (1, 2).

Apart from the selective degradation of LDs (lipophagy) (1, 3), there is growing evidence that autophagy or some element of the autophagic machinery plays an important role in LD biogenesis. First, there have been several independent observations of a reduction in LD number in knockout mice lacking autophagic components specifically in their hepatocytes (4, 5, 6, 7, 8). Second, the autophagic machinery participates in LD formation in hepatocytes and cardiomyocytes (7, 9), and deletion of autophagy-related genes such as Atg5 and Atg7 in the mouse liver decreases the level of triglycerides in the liver (9) and impairs ketogenesis (8, 10). Third, the loss of Fip200, an autophagy initiation factor, in mouse livers causes inactivation of nuclear receptors, liver X receptor α (LXRα), and peroxisome proliferator-activated receptor α (PPARα). These receptors play important roles in FA synthesis and oxidation, respectively (6). Therefore, their inactivation blocks liver steatosis under physiological fasting and high-fat diet conditions (6). Fourth, the supply of lipids provided through autophagy is required to replenish triglycerides in LDs (11), which provide molecules for FA oxidation. Fifth, the biogenesis of LD from FA supplied by starvation-induced autophagy prevents the lipotoxic effects of acylcarnitine (12), which disrupts mitochondrial membrane potential and mitochondrial function. However, whether autophagy participates in LD biogenesis directly and which step(s) within the process of LD biogenesis is affected by autophagy both remain unclear.

In this Research Article, we show that autophagy regulates FA and TG synthesis at the transcriptional level by fine-tuning the levels of nuclear receptor co-repressor 1 (NCoR1), a negative regulator of nuclear receptors, including LXRα, and that defective autophagy impairs physiological steatosis both under fasting conditions and after hepatectomy.

Results

Impairment of fasting-induced hepatosteatosis in liver-specific Atg7-knockout mice

NCoR1 is an autophagy-specific substrate (10, 13) and serves as a scaffold that facilitates the interaction of several docking proteins to fine-tune the transactivation of nuclear receptors such as LXRα and PPARα (14, 15). The interaction of NCoR1 with nuclear receptors and histone deacetylases is vital for nuclear receptor–mediated down-regulation of gene expression. Interestingly, LXRα and PPARα, both of which are negatively regulated by NCoR1, play opposing roles in lipid metabolism. Specifically, LXRα serves anabolic roles (FA and TG syntheses), whereas PPARα serves a catabolic role (β-oxidation). To determine whether NCoR1 accumulation due to autophagy suppression has an impact on LD biogenesis, we used hepatocyte-specific Atg7-knockout mice, Atg7f/f;Alb-Cre mice. The conversion of LC3-I to LC3-II was completely inhibited by the loss of Atg7 (Fig 1A), and p62/SQSTM1 (hereafter referred to p62), another autophagy-specific substrate, accumulated in mutant livers (Fig 1A), implying that autophagy was impaired. In agreement with previous reports (10, 13), we verified that NCoR1 accumulates in both the nuclear and cytoplasmic fractions prepared from livers of Atg7f/f;Alb-Cre mice (Fig 1A). Fasting decreased NCoR1 in both fractions from mutant livers, but levels of this protein were still higher than in control livers (Fig 1A). It has been reported that ubiquitination by a F-box-like/WD repeat–containing protein, TBLR1 directs NCoR1 into the proteasomal degradation and favors the exchange of corepressors for coactivators (16, 17). Thus, the ubiquitin-proteasome and autophagy-lysosomal pathways, both may contribute to degradation of NCoR1.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1. Fasting-induced hepatosteatosis is suppressed by loss of autophagy.

(A) LXRα and NCoR1 levels in Atg7-deficient mouse livers. Nuclear and cytoplasmic fractions, were prepared from the livers of 5-wk-old Atg7f/f (n = 3) and Atg7f/f;Alb-Cre (n = 3) mice under both fed and fasting conditions. These were subjected to immunoblotting using the indicated antibodies. Signal intensities of cytoplasmic NCoR1 and Gapdh and nuclear NCoR1, LXRα, and lamin B were measured by densitometry and were subtracted that of background. Bar graphs indicate the average values of the indicated cytoplasmic and nuclear proteins relative to Gapdh and lamin B, respectively. The average value of the Atg7f/f mice was set as 1. Data are means ± SE. *P < 0.05, **P < 0.01, and ***P < 0.001 as determined by Welch’s t test. (B) Gene expression of proteins related to FA and TG syntheses in Atg7-deficient livers. Total RNA was prepared from the livers of 5-wk-old Atg7f/f (n = 4) and Atg7f/f;Alb-Cre (n = 4) mice under both fed and fasting conditions. Values were normalized against the amount of mRNA in the livers of Atg7f/f mice under fed conditions. Real-time PCR analyses were performed as technical duplicates on each biological sample. Data are means ± SE. *P < 0.05 and **P < 0.01 as determined by Welch’s t test. (C) Oil Red O staining. Cryosections were prepared from livers of 5-wk-old Atg7f/f and Atg7f/f;Alb-Cre mice under both fed and fasting conditions and subjected to Oil Red O staining. Bar: 50 μm. (D) Electron microscopy. (C) Representative electron micrographs of hepatocytes from the same genotype mouse as in (C) are shown. Ratio of LD area was measured and plotted in the right graph. Data are means ± SE. *P < 0.05 and ***P < 0.001 as determined by Welch’s t test. Asterisks: LD, N: nucleus, Bar: 500 nm. (B, E) Liver triglyceride (TG) in mice described in (B). Data are means ± SE. **P < 0.01 and ***P < 0.001 as determined by Welch’s t test.

Source data are available for this figure.

Source Data for Figure 1[LSA-2019-00513_SdataF1.ai]

The expression of genes encoding enzymes involved in FA synthesis, including ATP citrate lyase (Acly), acetyl-CoA carboxylase (Acaca), fatty acid synthase (Fasn), and stearoyl-CoA desaturase (Scd1), which is regulated by LXRα, was markedly suppressed in the livers of Atg7f/f;Alb-Cre mice under fed conditions (Fig 1B). Under fasting conditions, transcript levels of enzymes related to FA synthesis in control livers decreased to a similar extent as those in mutant livers (Fig 1B). Remarkably, although the genes encoding enzymes related to TG synthesis, such as glycerol kinase (Gk) and diacylglycerol O-acyltransferase (Dgat1), and a transporter of FAs, fatty acid transport protein 2 (Fatp2), were up-regulated upon fasting, such induction was hardly observed in livers of Atg7f/f;Alb-Cre mice (Fig 1B). The level of Lxrα mRNA was lower in mutant livers than in control livers (Fig 1B), consistent with the idea that LXRα regulates its own expression (18). We verified that the level of nuclear LXRα protein in mutant livers was significantly lower compared with that of control livers (Fig 1A). Because the autophagic turnover of NCoR1 is necessary for effective β-oxidation in response to fasting (10, 13), these results suggest that under fasting conditions, both the catabolism (β-oxidation) and anabolism (TG synthesis) of FAs are primed by NCoR1 degradation. In fact, LDs detected by Oil Red O staining and electron microscopy showed that fasting-induced hepatosteatosis was suppressed by the loss of Atg7 (Fig 1C and D). Consistent with the morphological analyses, the amount of TG in control livers increased upon fasting, but such increase was milder in mutant livers (Fig 1E). Similarly, fasting-dependent hepatosteatosis was blocked in livers of Atg5f/f;Mx1-Cre mice one to 2 wk after intraperitoneal injection of polyinosinic-polycytidylic acid (pIpC), which induced liver-specific deletion of Atg5, another gene essential for autophagy (Fig S1A).

Figure S1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure S1. Oil Red O staining

Oil Red O staining. (A) Representative Oil Red O staining images of liver sections of 12-wk-old Atg5f/f and Atg5f/f;Mx1-Cre mice. Atg5f/f and Atg5f/f;Mx1-Cre mice were injected intraperitoneally with pIpC to delete Atg5 in the liver at 10 wk of age. Bars: 200 μm. (B) Representative Oil Red O staining images of liver sections of 5-mo-old Atg7f/f and Atg7f/f;Alb-Cre mice. Bars: 50 μm.

Impairment of partial hepatectomy-induced hepatosteatosis in liver-specific Atg7-knockout mice

After partial (70%) hepatectomy, the remnant liver recovers to its original liver weight within approximately 1 wk after hypertrophy of hepatocytes and about two rounds of cell division (19). The liver shows a transient and prominent accumulation of FAs 1 d after resection (20, 21), which supports rapid cell division and tissue regrowth (22). Next, we investigated whether autophagy is also involved in LD biogenesis in hepatocytes after hepatectomy. To this end, we carried out a 70% hepatectomy on the livers of Atg7f/f and Atg7f/f;Alb-Cre mice and followed them until 168 h after hepatectomy. The blood level of free FAs in control Atg7f/f mice gradually decreased after 70% hepatectomy, was at the lowest level at 18–24 h, and recovered 96–168 h after the hepatectomy (Fig 2A). In contrast, such fluctuation was not observed in mutant Atg7f/f;Alb-Cre mice (Fig 2A), suggesting the impairment of free FA uptake from blood in mutant hepatocytes.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2. Hepatectomy-induced hepatosteatosis is suppressed by loss of autophagy.

(A) Blood-free FA. 5-wk-old Atg7f/f (n = 4) and Atg7f/f;Alb-Cre (n = 3) mice were subjected to 70% hepatectomy. Subsequently, blood-free FA was measured at the indicated time points after hepatectomy. Data are means ± SE. **P < 0.01 as determined by Welch’s t test. (B) Gene expression of proteins related to FA and TG syntheses in Atg7-deficient livers after partial hepatectomy. (A) Total RNAs were prepared from mouse livers described in (A). Values were normalized against the amount of mRNA in Atg7f/f livers immediately after the hepatectomy. RT qPCR analyses were performed using cDNAs prepared from 5-wk-old Atg7f/f (n = 4) and Atg7f/f;Alb-Cre (n = 3) mice in duplicate. Data are means ± SE. *P < 0.05, **P < 0.01 and ***P < 0.001 as determined by Welch’s t test. (C) Oil Red O staining. 5-wk-old Atg7f/f and Atg7f/f;Alb-Cre mice were subjected to 70% hepatectomy. Liver sections were prepared at 0, 24, and 48 h after the hepatectomy and stained with Oil Red O. Data are representative of three separate experiments. Bar: 50 μm. (A, D) Liver triglyceride (TG) in mice described in (A). Data are means ± SE. *P < 0.05 and **P < 0.01 as determined by Welch’s t test. (E) Ki67-staining in liver paraffin sections prepared from 5-wk-old Atg7f/f and Atg7f/f;Alb-Cre mice at 0 and 48 h after hepatectomy. Number of Ki-67–positive cells (arrows) were counted and plotted as the number per square millimeter in the right graph (n = 3 mice). Bars: 50 μm. Data are means ± SEM. *P < 0.05 and ***P < 0.001, as determined by Welch’s t test. (A, F) Liver weights (% per body weight) of mice described in (A). Data are means ± SE. **pvov < 0.01 and ***P < 0.001 as determined by Welch’s t test.

Whereas the expression of the FA transporter genes, Fatp2 and Fatp5, in control livers was maintained up to 24 h after the hepatectomy, their expression levels in mutant livers were markedly decreased throughout the time course (Fig 2B). Moreover, we observed that in control livers, the transcription of genes that encode rate-limiting enzymes related to TG synthesis such as Dgat1 and Gk was dramatically increased up to 24 h. This induction was suddenly terminated 48 h after hepatectomy (Fig 2B). In contrast, the expression of enzymes involved in FA synthesis dropped to its lowest level 24 h and only recovered to or exceeded the basal level 96–168 h after hepatectomy (Fig 2B). In mutant livers, expression of almost all genes involved in both FA and TG synthesis, except Acly, were suppressed, especially during the early recovery phase after hepatectomy (Fig 2B). These results suggest that steatosis is defective in autophagy-deficient livers.

Oil Red O staining indicated hyperaccumulation of LDs in control hepatocytes 24 h after hepatectomy and near recovery 48 h after hepatectomy (Fig 2C). In contrast, such accumulation of LDs was not detectable in Atg7-deficient hepatocytes (Fig 2C). Consistent with those results, in control livers, the amount of TG markedly increased 24 h after hepatectomy and decreased 48 h after hepatectomy (Fig 2D). Such fluctuation was not observed in the case of mutant livers (Fig 2D). The hepatosteatosis that follows hepatectomy has been shown to play an essential role in hepatocyte proliferation (22). Therefore, we speculated that the loss of Atg7 is accompanied by the impairment of liver regeneration after partial hepatectomy. Indeed, immunohistochemical analysis with anti-Ki67 antibody showed fewer Ki67-positive cells in mutant livers compared with control livers (Fig 2E). Liver weight per unit body weight in control mice indicated 80% recovery after 168 h compared with the weight before hepatectomy (Fig 2F). Recovery was observed even in mutant mice, but to a much lesser extent (Fig 2F).

NCoR1 degradation through autophagy is necessary for increased level of LDs

Ultimately, we sought to elucidate the molecular mechanism by which loss of autophagy impairs LD accumulation and used HepG2 cells lacking ATG7 (Fig S2). We expressed either lacZ or ATG7 in ATG7-knockout HepG2 cells (#14) and compared the resulting phenotypic differences. As shown in Fig 3A, the conversion of LC3-I to LC3-II was restored in ATG7-/- HepG2 cells by the expression of ATG7 but not lacZ, and the level of p62 protein decreased upon overexpression of ATG7 but not lacZ. These results support the idea that autophagy is restored in ATG7-/- HepG2 cells expressing ATG7 (autophagy-competent) but not in cells expressing lacZ (autophagy-incompetent). Indeed, both the nuclear and cytoplasmic NCoR1 levels were lower in autophagy-competent HepG2 cells than in incompetent cells (Fig 3A). In contrast, we observed a higher level of nuclear LXRα protein in autophagy-competent cells (Fig 3A). The expression of LXRα target genes in autophagy-competent cells was much higher than in incompetent cells (Fig 3B). BODIPY-staining revealed that LDs still form in autophagy-incompetent cells (Fig 3C), but the number and size of LDs were significantly smaller than those in autophagy-competent cells (Fig 3C). In agreement with these results, we found that the amount of TG in autophagy-competent cells was higher than in incompetent cells (Fig 3D).

Figure S2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure S2. Immunoblot analysis.

Both nuclear and cytoplasmic fractions were prepared from parental and ATG7-knockout HepG2 cells (#4, #14, and #26) and subjected to immunoblotting with the indicated antibodies. Data are representative of three separate experiments.

Source data are available for this figure.

Source Data for Figure S2[LSA-2019-00513_SdataFS2.ai]

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3. Decreased levels of LDs in ATG7-deficient cells.

(A) Immunoblot analysis. Either lacZ or ATG7 was expressed in ATG7-knockout HepG2 (#14) cells using an adenovirus system. 96 h after infection, both nuclear and cytoplasmic fractions were prepared and subjected to immunoblotting with the indicated antibodies. Data shown are representative of three separate experiments. Signal intensities of cytoplasmic NCoR1 and Gapdh and nuclear NCoR1, LXRα, and lamin B were measured by densitometry and were subtracted that of background. Bar graphs indicate the average values of the indicated cytoplasmic and nuclear proteins relative to Gapdh and lamin B, respectively. The average value of the ATG7-knockout HepG2 expressing lacZ was set as 1. Statistical analyses were performed using Welch’s t test. Data are means ± SE. *P < 0.05 and **P < 0.01 as determined by Welch’s t test. (B) RT-qPCR analysis. (A) Total RNAs were prepared from cells described in (A). Values were normalized against the amount of mRNA in ATG7-knockout HepG2 cells (#14) expressing lacZ (Autophagy-incompetent). RT qPCR analyses were performed using cDNAs prepared from autophagy-incompetent and competent HepG2 cells (n = 3) in duplicate. Data are means ± SE. *P < 0.05 and **P < 0.01 as determined by Welch’s t test. (C) BODIPY staining. Either lacZ or ATG7 was expressed in ATG7-knockout HepG2 (#14) cells using an adenovirus system. 96 h after infection, the cells were stained by BODIPY. Bars: 20 μm. The number and size of LDs were quantified by CellInsight CX5 High-Content Screening Platform. Statistical analyses were performed using Welch’s t test. Data are means ± SE. **P < 0.01 as determined by Welch’s t test. (D) Triglyceride levels. (A) Lysates were prepared from cells described in (A), and the concentration of TG in each lysate was determined by using the Abcam Triglyceride Assay Kit. Statistical analysis was performed using Welch’s t test. Data are means ± SE. *P < 0.05 as determined by Welch’s t test.

Next, we investigated whether NCoR1 accumulation in autophagy-incompetent cells directly affects the level of LDs. The reduced level of nuclear LXRα in autophagy-incompetent cells was increased by the knockdown of NCoR1 (Fig 4A). NCoR1 depletion restores gene expression of most LXRα targets in autophagy-incompetent cells (Fig 4B). Unexpectedly, the transcription of some LXRα targets in autophagy-incompetent cells, including Fatp2 and Dgat1, did not increase after NCoR1 ablation (Fig 4B), probably because of partial compensation by NCoR2, an NCoR1 family protein (23). NCoR1 knockdown in autophagy-incompetent cells had little effect on the size and number of LDs (Fig 4C) because NCoR1 ablation enhances both the anabolism and catabolism of FAs (14, 15). Regardless, we confirmed that the amount of TG in autophagy-incompetent cells was restored to a significant extent by silencing NCoR1 (Fig 4D). On balance, these results suggest that NCoR1 accumulation due to defective autophagy suppresses LXRα transactivation, resulting in the impairment of FA and TG syntheses and of LD formation.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4. Knockdown of NCoR1 restores decreased levels of LDs in ATG7-deficient cells.

(A) Immunoblot analysis. ATG7-knockout HepG2 (#14) cells were infected with adenovirus for lacZ (Autophagy−) or ATG7 (Autophagy+) expression. The cells were simultaneously treated with either NCoR1-specific or scrambled control siRNA. 48 h after infection, the cells were re-treated with either NCoR1-specific or control siRNA and cultured for an additional 48 h. Thereafter, both nuclear and cytoplasmic fractions were prepared and subjected to immunoblotting with the indicated antibodies. Data are representative of three separate experiments. Signal intensities of cytoplasmic NCoR1 and GAPDH and nuclear NCoR1, LXRα, and lamin B were measured by densitometry and were subtracted that of background. Bar graphs indicate the average values of the indicated cytoplasmic and nuclear proteins relative to GAPDH and lamin B, respectively. The average value of the ATG7-knockout HepG2 expressing lacZ was set as 1. Statistical analyses were performed using Welch’s t test. Data are means ± SE. *P < 0.05, and **P < 0.01 as determined by Welch’s t test. (B) RT qPCR analysis. (A) Total RNAs were prepared from cells described in (A). Values were normalized against the amount of mRNA in lacZ-expressing ATG7-knockout HepG2 cells treated with control siRNA. RT qPCR analyses were performed using cDNAs prepared from each biological sample (n = 3) in duplicate. Data are means ± SE. *P < 0.05, **P < 0.01, and ***P < 0.001 as determined by Welch’s t test. (C) BODIPY staining. (A) ATG7-knockout HepG2 (#14) cells were treated as described in (A). Bars: 20 μm. The number and size of LDs were quantified by CellInsight CX5 High-Content Screening Platform. Statistical analyses were performed using Welch’s t test. Data are means ± SE. (D) Triglyceride levels. (A) Lysates were prepared from cells described in (A), and the concentration of TG in each lysate was determined using the Abcam Triglyceride Assay Kit. Statistical analysis was performed using Welch’s t test. Data are means ± SE. *P < 0.05 and **P < 0.01 as determined by Welch’s t test.

Discussion

Our finding differs from a prior report that mouse hepatocytes lacking Atg7 increase the size and the number of LDs (3). The main difference in experimental settings between this prior study and ours is the age of the genetically modified Atg7f/fAlb-Cre mice. While we used 5-wk-old Atg7f/f;Alb-Cre mice, Singh R et al (3), used 4-mo-old mice. Under conditions where the regeneration of mature hepatocytes is defective, such as the lack of β-catenin, hepatic oval cells proliferate and differentiate into hepatocytes and cholangiocytes, both of which replace the liver mass with aging (24). During active proliferation, most hepatic progenitor cells derived from oval cells undergo maturation arrest and become dedifferentiated, but these progenitor-derived immature hepatocytes possess a high potential for developing into liver tumors. Hepatocyte-specific ablation of β-catenin, in fact, promotes tumorigenesis (24). Likewise, the long-term suppression of autophagy in mouse livers is accompanied by tumorigenesis (25, 26), suggesting that autophagy-defective hepatocytes may lose the ability to regenerate and that the hepatic oval cells may compensate it. Remarkably, both hepatocytes and cholangiocytes differentiated from oval cells express albumin at negligible levels (24). In fact, we observed the presence of hepatocytes that lack p62-positive structures mosaically in aged Atg7f/f;Alb-Cre mice (i.e., autophagy-competent hepatocytes) (data not shown). Thus, we speculate that the livers of aged Atg7f/f;Alb-Cre mice are partially composed of Atg7-intact hepatocytes derived from oval cells and that such hepatocytes accumulate LDs aggressively to compensate for the dysfunction of Atg7-deficient hepatocytes. Indeed, some perivenous hepatocytes in 5-mo-old Atg7f/f;Alb-Cre mice contained many LDs (Fig S1B).

In the present study, we showed prominent accumulation of NCoR1 protein and impairment of lipogenesis in Atg7-knockout mice livers. As already described, long-term suppression of autophagy in mouse livers causes adenomagenesis, but does not progress to malignancy. However, the exact molecular mechanism still remains unclear. Remarkably, decreased expression of NCoR1, focal deletion of 17p11.2 containing NCoR1 and mutations of NCoR1 have been specified in human hepatocellular carcinoma (27, 28, 29). Meanwhile, cancer cells activate de novo FA synthesis to provide essential structural components and substrates for the generation of signaling molecules, and lipid synthesis contributes to cellular processes linked to tumor progression (30). Therefore, resistance of the liver-specific Atg7-knockout mice to progress from benign adenoma to liver cancer (25, 26) might be due to persistent expression of NCoR1.

Autophagy provides a substantial amount of FAs through the degradation of organelles under nutrient-deprived conditions (11). A robust influx of FAs from the blood into peripheral cells such as hepatocytes occurs under fasting conditions or after hepatectomy (20, 21). The increased level of intracellular FAs due to starvation-induced autophagy and/or fasting-triggered influx provides fuel for β-oxidation to produce energy; however, because β-oxidation intermediates such as acylcarnitine have a cytotoxic effect (12), cells have to maintain the levels of intracellular FAs below certain limits. In fact, DGAT1-mediated TG synthesis under nutrient-deprived conditions, when the amount of intracellular FAs is excessive, is necessary to mitigate the lipotoxic cellular damage caused by acylcarnitine (12). It is worth noting that the loss of autophagy in mouse livers is accompanied by NCoR1 accumulation, resulting in increased levels of acylcarnitine, in particular under fasting conditions (10, 13). We conclude that fine-tuning of NCoR1 protein levels through autophagy regulates the level of LDs to mitigate lipotoxicity.

Materials and Methods

Cell culture

HepG2 cells were grown in DMEM containing 10% FBS, 5 U/ml penicillin, and 50 μg/ml streptomycin. For knockdown experiments, HepG2 cells were transfected with 25 nM SMARTpool siRNA for NCoR1 using DharmaFECT 1 (Thermo Fisher Scientific). ATG7-knockout HepG2 cells (10) were used in this study.

Mice

Atg7f/f (31), Atg7f/f;Alb-Cre (32), Atg5f/f (33), and Atg5f/f;Mx1-Cre (33) mice in the C57BL/6 genetic background were used in this study. Mice were housed in specific pathogen–free facilities, and the Ethics Review Committees for Animal Experimentation of Niigata University, the University of Tokyo, and Jaunted University approved the experimental protocol. The concentration of liver triglycerides was determined using the Triglyceride Assay Kit, ab65336 (Abcam). Free FAs in plasma were analyzed by SRL (Tokyo, Japan). Fasting to 6-wk-old male mice was started at 8 pm and then continued during 24 h. After cervical dislocation of the fasted mice and control fed mice, their livers were removed. Partial hepatectomy (PHx) was performed in 6-wk-old male mice. Mice were anesthetized with an intraperitoneal injection of 0.05 ml/10 g body weight of a mixed anesthetic agents, consisting of medetomidine (0.06 mg/ml), midazolam (0.8 mg/ml), and butorphanol (1 mg/ml) in sterile normal saline and subjected to approximately 70% PHx by removing the left lateral and median lobes after midventral laparotomy. The mortality rate after 70% PHx was <1%. At indicated time points after 70% PHx, the mice were euthanized by cervical dislocation, and their livers were removed.

Immunoblot analysis

Livers were homogenized in 0.25 M sucrose, 10 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (Hepes) (pH 7.4), and 1 mM DTT. Nuclear and cytoplasmic fractions from livers and cultured cells were prepared using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific). Samples were subjected to SDS–PAGE, and transferred to a polyvinylidene difluoride membrane thereafter (IPVH00010; Merck). Antibodies against LXRα (ab28478; Abcam; 1:500), PPARα (ab8934; Abcam; 1:500), NCoR1 (#5948S; Cell Signaling Technology; 1:500), Atg7 (013-22831; Wako Pure Chemical Industries; 1:1,000), p62 (GP62-C; Progen Biotechnik GmbH; 1:1,000), LC3B (#2775; Cell Signaling Technology; 1:500), Gapdh (MAB374; Merck Millipore Headquarters; 1: 1,000), and lamin B (M-20; Santa Cruz Biotechnology; 1:200) were purchased from the indicated suppliers. Blots were incubated with horseradish peroxidase-conjugated goat antimouse IgG (H+L) (115-035-166; Jackson ImmunoResearch Laboratories, Inc.), goat antirabbit IgG (H+L) (111-035-144; Jackson ImmunoResearch Laboratories, Inc.), or goat anti-guinea pig IgG (H+L) antibody (106-035-003; Jackson ImmunoResearch Laboratories, Inc.), and visualized by chemiluminescence. Band density was measured using the software MultiGauge V3.2 (FUJIFILM Corporation).

RT-qPCR (real-time quantitative reverse transcriptase PCR)

Using the Transcriptor First-Strand cDNA Synthesis Kit (Roche Applied Science), cDNA was synthesized from 1 μg of total RNA. RT qPCR was performed using the LightCycler 480 Probes Master mix (Roche Applied Science) on a LightCycler 480 (Roche Applied Science). Signals from human and mouse samples were normalized against GAPDH and Gusb (ß-glucuronidase) mRNA, respectively. The sequences of primers used for gene expression analysis in either mouse livers or human cell lines are provided in Table S1.

Table S1 Primer sequences used for RT qPCR.

Histological examinations

Excised liver tissues were fixed by immersing in 0.1 M PB (pH 7.4) containing 4% paraformaldehyde and 4% sucrose. They were embedded in frozen optimal cutting temperature-compound or paraffin. The cryosections were stained with Oil Red O, and the paraffin sections were stained with rabbit anti-Ki67 antibody (clone SP6; Thermo Fisher Scientific) followed by N-Histofine simple stain mouse MAX PO kit (NICHIREI BIOSCIENCES) using 3,3′-diaminobenzidine. They were observed with a light microscope (BX51; Olympus). For quantification, Ki67-positive cells were counted in five rectangular regions (433 × 326 µm) per liver section of each mouse. Three to four mice were included in this analysis.

Electron microscopy

Livers were fixed by immersing in 0.1 M PB containing 2% paraformaldehyde and 2% glutaraldehyde. They were post-fixed with 1% OsO4, embedded in Epon812, and sectioned for observation with an electron microscopy (JM-1200EX; JEOL). For quantification, area ratio of LDs was measured in 20 hepatocytes for each mouse. Three mice were included in this analysis.

Microscopy for cultured cells

For staining of LDs, the cells were incubated with 1 μg/ml BODIPY 493/503 (D3922; Thermo Fisher Scientific) diluted in PBS for 15 min and extensively washed with PBS. Finally, the cells were incubated for 5 min with 10 μg/ml of Hoechst 33342 diluted in PBS, washed with PBS and mounted on slides with Prolong Gold antifade mounting solution (Thermo Fisher Scientific). The cells were imaged using a confocal laser-scanning microscope (Olympus, FV1000) with a UPlanSApo ×60 NA 1.40 oil objective lens. Ten fields of cells were imaged for each experimental condition with a CellInsight CX5 High-Content Screening Platform (Thermo Fisher Scientific) using HCS Studio software.

Statistical analysis

Values, including those displayed in the graphs, are means ± SE. Statistical analysis was performed using the unpaired t test (Welch test). A P value less than 0.05 was considered to indicate statistical significance.

Acknowledgements

We thank K Kanno (Fukushima Medical University) for his help in histological analyses. M Komatsu is supported by the Grants-in-Aid for Scientific Research on Innovative Areas (19H05706 to M Komatsu), the Japan Society for the Promotion of Science (an A3 foresight program, to M Komatsu and 18H02611 to M Komatsu), and the Takeda Science Foundation (to M Komatsu).

Author Contributions

  • S-s Takahashi: data curation, formal analysis, and investigation.

  • Y-S Sou: data curation, formal analysis, validation, and investigation.

  • T Saito: data curation, formal analysis, and investigation.

  • A Kuma: data curation, formal analysis, and investigation.

  • T Yabe: formal analysis and investigation.

  • Y Sugiura: formal analysis and investigation.

  • H-C Lee: formal analysis and investigation.

  • M Suematsu: supervision.

  • T Yokomizo: supervision.

  • M Koike: supervision.

  • S Terai: supervision.

  • N Mizushima: conceptualization and supervision.

  • S Waguri: data curation, formal analysis, supervision, and investigation.

  • M Komatsu: conceptualization, data curation, formal analysis, supervision, funding acquisition, and writing—original draft, review, and editing.

Conflict of Interest Statement

The authors declare that they have no conflict of interest.

  • Received August 2, 2019.
  • Revision received December 18, 2019.
  • Accepted December 18, 2019.
  • © 2019 Takahashi et al.
Creative Commons logoCreative Commons logohttps://creativecommons.org/licenses/by/4.0/

This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

References

  1. 1.↵
    1. Olzmann JA,
    2. Carvalho P
    (2019) Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol 20: 137–155. doi:10.1038/s41580-018-0085-z
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Henne WM,
    2. Reese ML,
    3. Goodman JM
    (2018) The assembly of lipid droplets and their roles in challenged cells. EMBO J 37: e98947. doi:10.15252/embj.201898947
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Singh R,
    2. Kaushik S,
    3. Wang Y,
    4. Xiang Y,
    5. Novak I,
    6. Komatsu M,
    7. Tanaka K,
    8. Cuervo AM,
    9. Czaja MJ
    (2009) Autophagy regulates lipid metabolism. Nature 458: 1131–1135. doi:10.1038/nature07976
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Kim KH,
    2. Jeong YT,
    3. Oh H,
    4. Kim SH,
    5. Cho JM,
    6. Kim YN,
    7. Kim SS,
    8. Kim DH,
    9. Hur KY,
    10. Kim HK, et al.
    (2013) Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 19: 83–92. doi:10.1038/nm.3014
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Kwanten WJ,
    2. Vandewynckel YP,
    3. Martinet W,
    4. De Winter BY,
    5. Michielsen PP,
    6. Van Hoof VO,
    7. Driessen A,
    8. Timmermans JP,
    9. Bedossa P,
    10. Van Vlierberghe H, et al.
    (2016) Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice. Am J Physiol Gastrointest Liver Physiol 311: G599–G609. doi:10.1152/ajpgi.00418.2015
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ma D,
    2. Molusky MM,
    3. Song J,
    4. Hu CR,
    5. Fang F,
    6. Rui C,
    7. Mathew AV,
    8. Pennathur S,
    9. Liu F,
    10. Cheng JX, et al.
    (2013) Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD. Mol Endocrinol 27: 1643–1654. doi:10.1210/me.2013-1153
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Shibata M,
    2. Yoshimura K,
    3. Tamura H,
    4. Ueno T,
    5. Nishimura T,
    6. Inoue T,
    7. Sasaki M,
    8. Koike M,
    9. Arai H,
    10. Kominami E, et al.
    (2010) LC3, a microtubule-associated protein1A/B light chain3, is involved in cytoplasmic lipid droplet formation. Biochem Biophys Res Commun 393: 274–279. doi:10.1016/j.bbrc.2010.01.121
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Takagi A,
    2. Kume S,
    3. Kondo M,
    4. Nakazawa J,
    5. Chin-Kanasaki M,
    6. Araki H,
    7. Araki S,
    8. Koya D,
    9. Haneda M,
    10. Chano T, et al.
    (2016) Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation. Sci Rep 6: 18944. doi:10.1038/srep18944
    OpenUrlCrossRef
  9. 9.↵
    1. Shibata M,
    2. Yoshimura K,
    3. Furuya N,
    4. Koike M,
    5. Ueno T,
    6. Komatsu M,
    7. Arai H,
    8. Tanaka K,
    9. Kominami E,
    10. Uchiyama Y
    (2009) The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun 382: 419–423. doi:10.1016/j.bbrc.2009.03.039
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Saito T,
    2. Kuma A,
    3. Sugiura Y,
    4. Ichimura Y,
    5. Obata M,
    6. Kitamura H,
    7. Okuda S,
    8. Lee HC,
    9. Ikeda K,
    10. Kanegae Y, et al.
    (2019) Autophagy regulates lipid metabolism through selective turnover of NCoR1. Nat Commun 10: 1567. doi:10.1038/s41467-019-08829-3
    OpenUrlCrossRef
  11. 11.↵
    1. Rambold AS,
    2. Cohen S,
    3. Lippincott-Schwartz J
    (2015) Fatty acid trafficking in starved cells: Regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell 32: 678–692. doi:10.1016/j.devcel.2015.01.029
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Nguyen TB,
    2. Louie SM,
    3. Daniele JR,
    4. Tran Q,
    5. Dillin A,
    6. Zoncu R,
    7. Nomura DK,
    8. Olzmann JA
    (2017) DGAT1-dependent lipid droplet biogenesis protects mitochondrial function during starvation-induced autophagy. Dev Cell 42: 9–21.e5. doi:10.1016/j.devcel.2017.06.003
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Iershov A,
    2. Nemazanyy I,
    3. Alkhoury C,
    4. Girard M,
    5. Barth E,
    6. Cagnard N,
    7. Montagner A,
    8. Chretien D,
    9. Rugarli EI,
    10. Guillou H, et al.
    (2019) The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARalpha. Nat Commun 10: 1566. doi:10.1038/s41467-019-09598-9
    OpenUrlCrossRef
  14. 14.↵
    1. Mottis A,
    2. Mouchiroud L,
    3. Auwerx J
    (2013) Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev 27: 819–835. doi:10.1101/gad.214023.113
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Perissi V,
    2. Jepsen K,
    3. Glass CK,
    4. Rosenfeld MG
    (2010) Deconstructing repression: Evolving models of co-repressor action. Nat Rev Genet 11: 109–123. doi:10.1038/nrg2736
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Perissi V,
    2. Aggarwal A,
    3. Glass CK,
    4. Rose DW,
    5. Rosenfeld MG
    (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116: 511–526. doi:10.1016/s0092-8674(04)00133-3
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Perissi V,
    2. Scafoglio C,
    3. Zhang J,
    4. Ohgi KA,
    5. Rose DW,
    6. Glass CK,
    7. Rosenfeld MG
    (2008) TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell 29: 755–766. doi:10.1016/j.molcel.2008.01.020
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Li Y,
    2. Bolten C,
    3. Bhat BG,
    4. Woodring-Dietz J,
    5. Li S,
    6. Prayaga SK,
    7. Xia C,
    8. Lala DS
    (2002) Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism. Mol Endocrinol 16: 506–514. doi:10.1210/me.16.3.506
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Taub R
    (2004) Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 5: 836–847. doi:10.1038/nrm1489
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Schofield PS,
    2. Sugden MC,
    3. Corstorphine CG,
    4. Zammit VA
    (1987) Altered interactions between lipogenesis and fatty acid oxidation in regenerating rat liver. Biochem J 241: 469–474. doi:10.1042/bj2410469
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Tijburg LB,
    2. Nyathi CB,
    3. Meijer GW,
    4. Geelen MJ
    (1991) Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy. Biochem J 277: 723–728. doi:10.1042/bj2770723
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Shteyer E,
    2. Liao Y,
    3. Muglia LJ,
    4. Hruz PW,
    5. Rudnick DA
    (2004) Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 40: 1322–1332. doi:10.1002/hep.20462
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Shimizu H,
    2. Astapova I,
    3. Ye F,
    4. Bilban M,
    5. Cohen RN,
    6. Hollenberg AN
    (2015) NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. Mol Cell Biol 35: 555–565. doi:10.1128/mcb.01208-14
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Wang EY,
    2. Yeh SH,
    3. Tsai TF,
    4. Huang HP,
    5. Jeng YM,
    6. Lin WH,
    7. Chen WC,
    8. Yeh KH,
    9. Chen PJ,
    10. Chen DS
    (2011) Depletion of beta-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development. Proc Natl Acad Sci U S A 108: 18384–18389. doi:10.1073/pnas.1116386108
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Takamura A,
    2. Komatsu M,
    3. Hara T,
    4. Sakamoto A,
    5. Kishi C,
    6. Waguri S,
    7. Eishi Y,
    8. Hino O,
    9. Tanaka K,
    10. Mizushima N
    (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25: 795–800. doi:10.1101/gad.2016211
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Inami Y,
    2. Waguri S,
    3. Sakamoto A,
    4. Kouno T,
    5. Nakada K,
    6. Hino O,
    7. Watanabe S,
    8. Ando J,
    9. Iwadate M,
    10. Yamamoto M, et al.
    (2011) Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193: 275–284. doi:10.1083/jcb.201102031
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Bhaskara S,
    2. Knutson SK,
    3. Jiang G,
    4. Chandrasekharan MB,
    5. Wilson AJ,
    6. Zheng S,
    7. Yenamandra A,
    8. Locke K,
    9. Yuan JL,
    10. Bonine-Summers AR, et al.
    (2010) Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18: 436–447. doi:10.1016/j.ccr.2010.10.022
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu
    2. Cancer Genome Atlas Research Network
    (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169: 1327–1341.e23. doi:10.1016/j.cell.2017.05.046
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Totoki Y,
    2. Tatsuno K,
    3. Covington KR,
    4. Ueda H,
    5. Creighton CJ,
    6. Kato M,
    7. Tsuji S,
    8. Donehower LA,
    9. Slagle BL,
    10. Nakamura H, et al.
    (2014) Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 46: 1267–1273. doi:10.1038/ng.3126
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Rohrig F,
    2. Schulze A
    (2016) The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer 16: 732–749. doi:10.1038/nrc.2016.89
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Komatsu M,
    2. Waguri S,
    3. Ueno T,
    4. Iwata J,
    5. Murata S,
    6. Tanida I,
    7. Ezaki J,
    8. Mizushima N,
    9. Ohsumi Y,
    10. Uchiyama Y, et al.
    (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169: 425–434. doi:10.1083/jcb.200412022
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Komatsu M,
    2. Waguri S,
    3. Koike M,
    4. Sou YS,
    5. Ueno T,
    6. Hara T,
    7. Mizushima N,
    8. Iwata J,
    9. Ezaki J,
    10. Murata S, et al.
    (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149–1163. doi:10.1016/j.cell.2007.10.035
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Hara T,
    2. Nakamura K,
    3. Matsui M,
    4. Yamamoto A,
    5. Nakahara Y,
    6. Suzuki-Migishima R,
    7. Yokoyama M,
    8. Mishima K,
    9. Saito I,
    10. Okano H, et al.
    (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889. doi:10.1038/nature04724
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Loss of autophagy impairs physiological steatosis by accumulation of NCoR1
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Defective physiological steatosis by loss of autophagy
Shun-saku Takahashi, Yu-Shin Sou, Tetsuya Saito, Akiko Kuma, Takayuki Yabe, Yuki Sugiura, Hyeon-Cheol Lee, Makoto Suematsu, Takehiko Yokomizo, Masato Koike, Shuji Terai, Noboru Mizushima, Satoshi Waguri, Masaaki Komatsu
Life Science Alliance Dec 2019, 3 (1) e201900513; DOI: 10.26508/lsa.201900513

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Defective physiological steatosis by loss of autophagy
Shun-saku Takahashi, Yu-Shin Sou, Tetsuya Saito, Akiko Kuma, Takayuki Yabe, Yuki Sugiura, Hyeon-Cheol Lee, Makoto Suematsu, Takehiko Yokomizo, Masato Koike, Shuji Terai, Noboru Mizushima, Satoshi Waguri, Masaaki Komatsu
Life Science Alliance Dec 2019, 3 (1) e201900513; DOI: 10.26508/lsa.201900513
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 3, No. 1
January 2020
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Physiology

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • NLRP3 controls ATM activation
  • RIF1 stabilizes replication domains
  • Chromatin context-dependent interferon response
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2023 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.